Searched for
DCGI CHIEF
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...- Roche brings 7-minute lung cancer shot to IndiaRoche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduct...
- Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancerRoche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven min...
- Dr. Reddy’s Lab launches India’s first DCGI-approved Semaglutide injection for Type 2 DiabetesDr. Reddy's Laboratories has launched Obeda, a generic semaglutide injection for Type 2 diabetes, becoming the first Indian company to rece...
- Ozempic row: Delhi HC seeks government reply over delay in off-label drug misuse probeIn a significant move, the Delhi High Court has summoned the government and drug regulatory bodies to address a contempt petition regarding...
- DCGI suspends nod to Entod's new eye drops over unapproved 'claims'India's drug regulator has suspended Entod Pharmaceuticals' permission to manufacture and sell PresVu Eye Drops. The company did not obtain...
- DCGI chief VG Somani gets three months extensionThe extension period will come to effect from November 11. This is the second extension that Somani got. His term was set to end on August ...
- Tenure of DCGI chief V G Somani extended by three monthsDr V G Somani to continue working as Drugs Controller General of India (DCGI) Chief for the next three months, according to an order issued...
- COVID: NTAGI may recommend vaccination for 5-12 age group on FridayPrime Minister Narendra Modi in an interaction with chief ministers on Wednesday had said that the government's priority is to vaccinate al...
- What Covovax could mean for Indian studentsCovovax is technology transfer of the vaccine developed by US-based Novavax. Its recent trials prove improved efficacy against the very new...
- Pfizer, Moderna vaccines may soon be available in IndiaThe Drugs Controller General of India (DCGI) has done away with specific trials of COVID-19 vaccines that have been approved by other inter...
- Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt"Covaxin has been approved by the Drugs Controller General of India (DCGI), for Phase II/III clinical trials in the age group of 2 to 18 ye...
- Arvind Kejriwal lauds scientists and doctors after approval to two COVID vaccinesThe Drugs Controller General of India (DCGI) on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, an...
- DCGI finds no link between Covid vaccine shot and 'adverse' reaction in Chennai volunteer during trial: SourcesThe DCGI arrived at the conclusion on Wednesday based on the recommendations of an independent expert committee which has also opined that ...
- Oxford vaccine: Kiran Mazumdar-Shaw seeks quick regulatory processing after UK nodShe cited reports according to which the UK's medicines and healthcare products regulatory agency (MHRA) is likely to grant EUA by mid Dece...
- Hopefully DCGI will give EUA for Oxford's vaccine immediately after MHRA nod: Mazumdar-ShawOn Monday, AstraZeneca had said one dosing regimen showed vaccine efficacy of 90 per cent when the vaccine was given as a half-dose followe...
- Hyderabad based Biophore India gets DCGI nod to manufacture COVID drug FavipiravirFavipiravir is an antiviral agent that was initially discovered and developed because of its activity against another RNA (ribonucleic acid...
- Polio vaccine contamination case: Bio-Med MD gets bail, drug inspectors apologise to courtBio-Med, a 43-year old Ghaziabad-based vaccine maker came under the scanner of the Drug regulator last month when the inspectors claimed th...
- Battle over stroke medicine between Boehringer and Gennova heats up at courtGennova didn’t follow the ethical guidelines issued by the Indian Council of Medical Research (ICMR) while designing its clinical study for...
- HC rejects Bayer plea on Nexavar copycatThe Delhi HC dismissed an appeal by German drugmaker Bayer that sought to stop Cipla from obtaining a marketing approval from the country’s...
Load More
